CA2048894A1 - Methode de traitement de la mastocytose - Google Patents
Methode de traitement de la mastocytoseInfo
- Publication number
- CA2048894A1 CA2048894A1 CA2048894A CA2048894A CA2048894A1 CA 2048894 A1 CA2048894 A1 CA 2048894A1 CA 2048894 A CA2048894 A CA 2048894A CA 2048894 A CA2048894 A CA 2048894A CA 2048894 A1 CA2048894 A1 CA 2048894A1
- Authority
- CA
- Canada
- Prior art keywords
- mast cell
- cell disease
- treating
- treating mast
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000035268 Mast Cell Activation disease Diseases 0.000 title abstract 2
- WJBLNOPPDWQMCH-MBPVOVBZSA-N Nalmefene Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=C)O)CC1)O)CC1CC1 WJBLNOPPDWQMCH-MBPVOVBZSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229960005297 nalmefene Drugs 0.000 abstract 1
- 229960003086 naltrexone Drugs 0.000 abstract 1
- DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 abstract 1
- 239000003887 narcotic antagonist Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/565,428 US5057322A (en) | 1990-08-10 | 1990-08-10 | Method of treating mast cell disease |
| US565,428 | 1990-08-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2048894A1 true CA2048894A1 (fr) | 1992-02-11 |
| CA2048894C CA2048894C (fr) | 1995-10-17 |
Family
ID=24258552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002048894A Expired - Fee Related CA2048894C (fr) | 1990-08-10 | 1991-08-09 | Methode de traitement de la mastocytose |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5057322A (fr) |
| EP (1) | EP0471525B1 (fr) |
| JP (1) | JP2559304B2 (fr) |
| AT (1) | ATE129154T1 (fr) |
| AU (1) | AU8166291A (fr) |
| CA (1) | CA2048894C (fr) |
| DE (1) | DE69113921T2 (fr) |
| DK (1) | DK0471525T3 (fr) |
| ES (1) | ES2078450T3 (fr) |
| GR (1) | GR3018335T3 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648355A (en) * | 1994-02-09 | 1997-07-15 | Kos Pharmaceutical, Inc. | Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| WO1997018781A1 (fr) * | 1995-11-20 | 1997-05-29 | University Of Miami | Procede pour traiter la dependance a la nicotine |
| US20030153590A1 (en) * | 2001-08-14 | 2003-08-14 | Oy Contral Pharma Ltd | Method of treating alcoholism or alcohol abuse |
| US7501433B2 (en) | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454142A (en) * | 1983-05-26 | 1984-06-12 | Key Pharmaceuticals, Inc. | Hyperkinetic child treatment agent |
| US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
| HU196376B (en) * | 1985-05-23 | 1988-11-28 | Sandoz Ag | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds |
| EP0245366A1 (fr) * | 1985-10-29 | 1987-11-19 | Baker Cummins Pharmaceuticals, Inc. | Procede et composition pour bloquer des reactions allergiques provoquees par des antigenes |
| US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
| US4877791A (en) * | 1988-11-01 | 1989-10-31 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for interestitial cystitis |
| US4923875A (en) * | 1989-07-10 | 1990-05-08 | Baker Cummins Pharmaceuticals, Inc. | Method for treatment of mast cell-mediated dermatologic disorders |
-
1990
- 1990-08-10 US US07/565,428 patent/US5057322A/en not_active Expired - Fee Related
-
1991
- 1991-08-06 AU AU81662/91A patent/AU8166291A/en not_active Abandoned
- 1991-08-08 JP JP3225233A patent/JP2559304B2/ja not_active Expired - Lifetime
- 1991-08-09 DK DK91307365.6T patent/DK0471525T3/da active
- 1991-08-09 AT AT91307365T patent/ATE129154T1/de not_active IP Right Cessation
- 1991-08-09 CA CA002048894A patent/CA2048894C/fr not_active Expired - Fee Related
- 1991-08-09 DE DE69113921T patent/DE69113921T2/de not_active Expired - Fee Related
- 1991-08-09 EP EP91307365A patent/EP0471525B1/fr not_active Expired - Lifetime
- 1991-08-09 ES ES91307365T patent/ES2078450T3/es not_active Expired - Lifetime
-
1995
- 1995-12-08 GR GR950403446T patent/GR3018335T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2078450T3 (es) | 1995-12-16 |
| US5057322A (en) | 1991-10-15 |
| CA2048894C (fr) | 1995-10-17 |
| DK0471525T3 (da) | 1996-02-19 |
| DE69113921T2 (de) | 1996-05-15 |
| DE69113921D1 (de) | 1995-11-23 |
| EP0471525B1 (fr) | 1995-10-18 |
| ATE129154T1 (de) | 1995-11-15 |
| GR3018335T3 (en) | 1996-03-31 |
| AU8166291A (en) | 1992-02-13 |
| JPH04230629A (ja) | 1992-08-19 |
| JP2559304B2 (ja) | 1996-12-04 |
| EP0471525A1 (fr) | 1992-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0373744A3 (fr) | Utilisation du nalméfène ou du naltrexone dans le traitement des maladies auto-immunes | |
| EP0377272A3 (fr) | Utilisation de nalméfène ou naltrexone pour l'obtention d'un médicament destiné au traitement de l'inflammation dans l'arthrite ou dans des maladies inflammatoires associées | |
| EP0367533A3 (fr) | Méthode pour le traitement de la cystite interstitielle | |
| EP0381194A3 (en) | Drug preparation applicable to oral mucosa | |
| GB2188630B (en) | Improvements in pharmaceutically acceptable salts | |
| AU7277987A (en) | Pharmaceutically active tetrahydronaphthalene derivatives | |
| NZ508037A (en) | A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer | |
| GEP20032965B (en) | Pharmaceutical Compound | |
| FI905674A (fi) | Menetelmä valmistaa farmaseuttisesti käyttökelpoisia 5,11-dihydro-6H-dipyrido/3,2-b:2',3'-e//1,4/diatsepin-6-oneja ja -tioneja | |
| CA2202531A1 (fr) | Lyophilisat de complexe lipide de camptothecines non hydrosolubles | |
| IT1255792B (it) | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda | |
| CA2048894A1 (fr) | Methode de traitement de la mastocytose | |
| WO1991018606A3 (fr) | Analgesiques actifs par voie orale ne creant pas d'accoutumance | |
| EP0649660A3 (fr) | Compositions pharmaceutiques pour l'administration parentérale, entérale et dermale d'agents actifs pratiquement insolubles, et procédé pour leur fabrication. | |
| GR900300082T1 (en) | Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine | |
| GB8921069D0 (en) | Pharmaceutically active compound,preparation and use | |
| AU631235B2 (en) | New oral pharmaceutical dosage form improving bioavailability | |
| Mann et al. | Inpatient medically supervised opioid withdrawal with buprenorphine alone or in combination with naltrexone | |
| Barzaghi et al. | Effect of antacids on famotidine bioavailability | |
| RU97122232A (ru) | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки | |
| CA2153570A1 (fr) | Composition pharmaceutique permettant de traiter la dependance a la nicotine | |
| RU93042104A (ru) | Противокашлевая композиция, содержащая декстрометорфан, способ ее применения | |
| RU99127690A (ru) | Способ лечения опийной наркомании |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |